Hainan Huluwa Pharmaceutical Group Co., Ltd. (SHA:605199)
China · Delayed Price · Currency is CNY 6.80
+0.16 (2.41%)
Feb 4, 2026, 3:00 PM CST
SHA:605199 Revenue
Hainan Huluwa Pharmaceutical Group had revenue of 175.05M CNY in the quarter ending September 30, 2025, with 21.87% growth. This brings the company's revenue in the last twelve months to 1.06B, down -31.37% year-over-year. In the year 2024, Hainan Huluwa Pharmaceutical Group had annual revenue of 1.41B, down -21.26%.
Revenue (ttm)
1.06B
Revenue Growth
-31.37%
P/S Ratio
2.56
Revenue / Employee
505.79K
Employees
2,103
Market Cap
2.72B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1.41B | -381.64M | -21.26% |
| Dec 31, 2023 | 1.80B | 280.14M | 18.49% |
| Dec 31, 2022 | 1.52B | 161.25M | 11.91% |
| Dec 31, 2021 | 1.35B | 192.09M | 16.53% |
| Dec 31, 2020 | 1.16B | -144.21M | -11.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Anhui Fengyuan Pharmaceutical | 4.15B |
| Enwei Pharmaceutical | 888.64M |
| ShanXi C&Y Pharmaceutical Group Co.,LTD. | 849.26M |
| Chengdu huasun technology group Inc. , LTD. | 658.28M |
| Ginwa Enterprise (Group) | 550.44M |
| Shaanxi Kanghui Pharmaceutical | 513.23M |
| Zhejiang Shapuaisi Pharmaceutical | 475.19M |
| Anhui Huangshan Capsule | 471.08M |